Advertisement

Asthma Which Was Not Asthma

  • Peter JandusEmail author
Chapter

Abstract

  • Acquired hypogammaglobulinemia should always be considered during the evaluation of a patient with a suspected antibody deficiency

  • Chronic corticosteroid use, antiepileptic drugs, and rituximab therapy, malignancies such as chronic lymphocytic leukemia, or lymphomas, nephrotic syndrome, protein-losing enteropathy and congenital lymphangiectasis, as well as HIV infection are considered as common causes of secondary hypogammaglobulinemia

  • Headaches are a typically associated with intravenous immunoglobulin infusions

  • Slowing or stopping the infusion for 15–30 minutes can reverse most of the acute reactions associated with IVIG infusion

  • Adequate hydration or prescribing acetaminophen or NSAIDs are among options to prevent headaches during IVIG treatment

Keywords

Hypogammaglobulinemia Asthma Autoimmunity CVID-like disorders 

References

  1. 1.
    Maarschalk-Ellerbroek LJ, de Jong PA, van Montfrans JM, Lammers JW, Bloem AC, Hoepelman AI, Ellerbroek PM. CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters. J Clin Immunol. 2014;34(6):642–54.CrossRefGoogle Scholar
  2. 2.
    Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, Espinosa-Rosales FJ, Hammarstrom L, Nonoyama S, Quinti I, Routes JM, Tang ML, Warnatz K. International Consensus Document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(1):38–59.CrossRefGoogle Scholar
  3. 3.
    Gathmann B, Mahlaoui N, Ceredih GL, Oksenhendler E, Warnatz K, Schulze I, Kindle G, Kuijpers TW, Dutch WID, van Beem RT, Guzman D, Workman S, Soler-Palacin P, De Gracia J, Witte T, Schmidt RE, Litzman J, Hlavackova E, Thon V, Borte M, Borte S, Kumararatne D, Feighery C, Longhurst H, Helbert M, Szaflarska A, Sediva A, Belohradsky BH, Jones A, Baumann U, Meyts I, Kutukculer N, Wagstrom P, Galal NM, Roesler J, Farmaki E, Zinovieva N, Ciznar P, Papadopoulou-Alataki E, Bienemann K, Velbri S, Panahloo Z, Grimbacher B, European Society for Immunodeficiencies Registry Working P. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(1):116–26.CrossRefGoogle Scholar
  4. 4.
    Urm SH, Yun HD, Fenta YA, Yoo KH, Abraham RS, Hagan J, Juhn YJ. Asthma and risk of selective IgA deficiency or common variable immunodeficiency: a population-based case-control study. Mayo Clin Proc. 2013;88(8):813–21.CrossRefGoogle Scholar
  5. 5.
    Agondi RC, Barros MT, Rizzo LV, Kalil J, Giavina-Bianchi P. Allergic asthma in patients with common variable immunodeficiency. Allergy. 2010;65(4):510–5.CrossRefGoogle Scholar
  6. 6.
    Agondi RC, Barros MT, Kokron CM, Cohon A, Oliveira AK, Kalil J, Giavina-Bianchi P. Can patients with common variable immunodeficiency have allergic rhinitis? Am J Rhinol Allergy. 2013;27(2):79–83.CrossRefGoogle Scholar
  7. 7.
    Lucas M, Hugh-Jones K, Welby A, Misbah S, Spaeth P, Chapel H. Immunomodulatory therapy to achieve maximum efficacy: doses, monitoring, compliance, and self-infusion at home. J Clin Immunol. 2010;30(Suppl 1):S84–9.CrossRefGoogle Scholar
  8. 8.
    Altenburg J, de Graaff CS, Stienstra Y, Sloos JH, van Haren EH, Koppers RJ, van der Werf TS, Boersma WG. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial. JAMA. 2013;309(12):1251–9.CrossRefGoogle Scholar
  9. 9.
    Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hockey H, Milne D, Fergusson W, Tuffery C, Sexton P, Storey L, Ashton T. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet. 2012;380(9842):660–7.CrossRefGoogle Scholar
  10. 10.
    Perez EE, Orange JS, Bonilla F, Chinen J, Chinn IK, Dorsey M, El-Gamal Y, Harville TO, Hossny E, Mazer B, Nelson R, Secord E, Jordan SC, Stiehm ER, Vo AA, Ballow M. Update on the use of immunoglobulin in human disease: a review of evidence. J Allergy Clin Immunol. 2017;139(3s):S1–s46.CrossRefGoogle Scholar
  11. 11.
    Rachid R, Bonilla FA. The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: a comprehensive review of the literature. J Allergy Clin Immunol. 2012;129(3):628–34.CrossRefGoogle Scholar
  12. 12.
    Tacquard C, Boudjedir K, Carlier M, Muller JY, Gomis P, Mertes PM. Hypersensitivity transfusion reactions due to IgA deficiency are rare according to French hemovigilance data. J Allergy Clin Immunol. 2017;140(3):884–5.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Division of Immunology and Allergology, Department of Internal MedicineUniversity Hospital and Medical FacultyGenevaSwitzerland

Personalised recommendations